RT Journal Article SR Electronic T1 Exposure to Technologists from Preparing and Administering Therapeutic 131I: How Frequently Should We Bioassay? JF Journal of Nuclear Medicine Technology JO J. Nucl. Med. Technol. FD Society of Nuclear Medicine SP 60 OP 62 DO 10.2967/jnmt.110.077297 VO 39 IS 1 A1 Amy Kopisch A1 Chris B. Martin A1 Vesper Grantham YR 2011 UL http://tech.snmjournals.org/content/39/1/60.abstract AB It is common for nuclear medicine technologists to perform procedures involving the preparation and administration of therapeutic levels of 131I-sodium iodide. This small study looked at the question of how much internal exposure a technologist receives, on average, while preparing and administering a therapeutic dose of 131I. Methods: The study estimated technologists’ intake of airborne 131I by measuring air concentrations in their breathing zone during therapeutic procedures using 131I capsules. The measurement was made by determining the radioactivity collected on a charcoal filter contained within a personal air sampler. The radioactivity captured by the charcoal filter was assessed in a well counter. Results: Given these data, we were able to estimate the average 131I intake of a technologist working in a general nuclear medicine department over a period of 1 y: about 19.2 kBq (0.52 μCi). Conclusion: The NRC requirement is to monitor workers who could inhale or ingest more than 185 kBq (5 μCi) of 131I in 1 y. The results of this small study suggest internal exposure rates that are well below the annual Nuclear Regulatory Commission trigger limits for individual bioassay.